Download presentation
Presentation is loading. Please wait.
1
Volume 152, Issue 1, Pages 61-67 (January 2019)
Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041) Jung-Yun Lee, Jeong-Yeol Park, Sang Yoon Park, Jeong-Won Lee, Jae Weon Kim, Yong Beom Kim, Dae Hoon Jeong, Kwang-Beom Lee, Tae-Hun Kim, In Ho Lee, Min Chul Choi, Ki Hyung Kim, Yong-Man Kim, Yong Jae Lee, Sokbom Kang, Eric Pujade-Lauraine Gynecologic Oncology Volume 152, Issue 1, Pages (January 2019) DOI: /j.ygyno Copyright © Terms and Conditions
2
Fig. 1 Patient disposition.
W-P, weekly paclitaxel; Topo, topotecan; AE, adverse event; BEV, bevacizumab; CT, chemotherapy. Gynecologic Oncology , 61-67DOI: ( /j.ygyno ) Copyright © Terms and Conditions
3
Fig. 2 Survival according to chemotherapy partner.
Gynecologic Oncology , 61-67DOI: ( /j.ygyno ) Copyright © Terms and Conditions
4
Fig. 3 Summary of treatment exposure.
Gynecologic Oncology , 61-67DOI: ( /j.ygyno ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.